, 0.3&#37

A Randomized, Placebo-Controlled, Double-Blind, Phase I Study to Evaluate the Safety and Pharmacokinetics of eye drop AVI-4015 in healthy volunteers

A phase 1 clinical trial to evaluate safety, tolerability, pharmacokinetic properties and effectiveness after applying an investigational cream to healthy adults and atopic dermatitis patients